# A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

> **NCT02494999** · PHASE3 · COMPLETED · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 1200 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **BIOLOGICAL:** 13-valent pneumococcal conjugate vaccine
- **BIOLOGICAL:** Prevnar 13

## Key facts

- **NCT ID:** NCT02494999
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2018-12
- **Final completion:** 2019-10
- **Target enrollment:** 1200 (ACTUAL)
- **Last updated:** 2020-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02494999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02494999, "A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02494999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*